Scientists have developed a novel surgical method allowing two retinal tissue grafts to be implanted in a single eye, advancing treatment strategies for dry age-related macular degeneration (AMD). This new approach enables side-by-side testing of grafts—one with retinal pigment epithelial (RPE) cells and one without—within the same lesion, using a specially designed clamp to maintain eye pressure and reduce damage.